T652-0250 Screening compound: N~6~-cycloheptyl-3-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-6-carboxamide

T652-0250 Screening compound: N~6~-cycloheptyl-3-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-6-carboxamide
T652-0250 Screening compound: N~6~-cycloheptyl-3-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T652-0250
N~6~-cycloheptyl-3-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T652-0250

Molecular Formula

C21H26FN3O (C21 H26 FN3 O)

Compound Name

N~6~-cycloheptyl-3-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-6-carboxamide

IUPAC name

N-cycloheptyl-3-(4-fluorophenyl)-5H6H7H8H-imidazo[12-a]pyridine-6-carboxamide

SMILES

O=C(C1Cn2c(-c(cc3)ccc3F)cnc2CC1)NC1CCCCCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

355.46

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.358

Distribution Coefficient, logD

3.467

Water Solubility, LogSw

-4.19

Polar Surface Area

35.857

Acid Dissociation Constant (pKa)

14.17

Base Dissociation Constant (pKb)

8.23

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

52.38

T652-0250 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Indoleamine 2,3-dioxygenase 1 Focused Library (5816 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T652-0250 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T652-0250?
Check Price and Availability of T652-0250, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T652-0250 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T652-0250
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T652-0250
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T652-0250 available by request